Concepedia

Shiri Wallach

SW

Statistics

Publications

2

Citations

45

H-Index

2

Active since

2023

Affiliations

Stanford University(Current)

Novartis (United Kingdom)

Novartis Gene Therapies, Inc. (United States)

Primary Children's Hospital

Novartis (Ireland)

Shiri Wallach is an author at Stanford University specializing in onasemnogene abeparvovec therapy, infantile spinal muscular atrophy, and spinal muscular atrophy.

Publications per year

2023–2023

2

Publications

2

Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment

Katlyn McGrattan, Richard D. Shell, Rebecca Hurst-Davis et al. · Journal of Neuromuscular Diseases · 2023 · 29 citations · Full text

, , +16

Onasemnogene abeparvovec preserves bulbar function in infants with presymptomatic spinal muscular atrophy: a post-hoc analysis of the SPR1NT trial

Richard D. Shell, Katlyn McGrattan, Rebecca Hurst-Davis et al. · Neuromuscular Disorders · 2023 · 16 citations · Full text

, , +13

1–2 of 2